NeuroBionics

📍 Somerville, United States🗓 Founded 2023👥 16 employees💰 Last funded Jan 2026
Biotechnology Research🌐 neurobionics.io
Website LinkedIn
NeuroBionics is pioneering the future of precision bioelectronic medicine by developing the next generation of implantable devices, designed to seamlessly interface with the human body. Our core technology lies in flexible, multifunctional fibers the size of a human hair, which can record and stimulate neural activity, deliver drugs, and ablate tissue. Using an endovascular approach, we will navigate our microscopic-sized flexible fiber implant through the intricate network of blood vessels to deliver precise therapeutic intervention to neural tissue. By making neural interfacing a minimally-invasive procedure, we will revolutionize deep brain stimulation and broaden access to this lifechanging therapy. By doing so, we aim to improve the lives of millions grappling with conditions like Parkinsons disease, essential tremor, epilepsy, and depression.
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2023
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in NeuroBionics?
NeuroBionics has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did NeuroBionics last raise funding?
The most recent investment in NeuroBionics recorded on gritt.io was in January 2026.
When was NeuroBionics founded?
NeuroBionics was founded in 2023.
What industry is NeuroBionics in?
NeuroBionics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is NeuroBionics based?
NeuroBionics is headquartered in Somerville, United States.